An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
The co-founder of Promise Fund and the Susan G. Komen Foundation highlights cervical cancer, one of the most preventable and ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...
A new study from Public Health Scotland shows that no cervical cancer cases have been detected in fully vaccinated women ...
The health ministry is planning to include the Human papillomavirus (HPV) vaccination in the country’s immunization program ...
THE symptoms of late-stage cervical cancer - pelvic pain, foul-smelling bloody discharge, frequent vomiting and bloating, are ...
Human Papillomavirus (HPV): A group of more than 200 related viruses, some of which can cause cancer. Immunogenicity: The ability of a substance, such as a vaccine, to provoke an immune response ...
Purpose: Human papillomavirus (HPV) disease and vaccines and several controversial issues associated with vaccine administration are reviewed. Summary: HPV infection is the most common sexually ...
While discussing the financial constraints of the vaccine industry, Poonawalla called for relaxing price caps to encourage ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...